Insider Transactions in Q2 2024 at Teladoc Health, Inc. (TDOC)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
468
-1.69%
|
$5,148
$11.04 P/Share
|
|
Jun 03
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
4,015
-8.87%
|
$44,165
$11.16 P/Share
|
|
Jun 03
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,040
-1.42%
|
$11,440
$11.16 P/Share
|
|
Jun 03
2024
|
James L. Cave INTERIM CAO |
SELL
Open market or private sale
|
Direct |
854
-6.41%
|
$9,394
$11.16 P/Share
|
|
Jun 03
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,096
-3.37%
|
$23,056
$11.16 P/Share
|
|
Jun 03
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,790
-5.94%
|
$19,690
$11.16 P/Share
|
|
Jun 03
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,122
-3.89%
|
$12,342
$11.16 P/Share
|
|
Jun 03
2024
|
Laizer Kornwasser Advisor to the CEO |
SELL
Open market or private sale
|
Direct |
4,812
-5.04%
|
$52,932
$11.16 P/Share
|
|
Jun 03
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,246
-5.8%
|
$46,706
$11.16 P/Share
|
|
Jun 03
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,627
-4.14%
|
$17,897
$11.16 P/Share
|
|
Jun 03
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
1,807
-4.15%
|
$19,877
$11.16 P/Share
|
|
Jun 03
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,807
-10.06%
|
$96,877
$11.16 P/Share
|
|
May 31
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
7,803
+5.67%
|
-
|
|
May 31
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,854
+0.97%
|
-
|
|
May 31
2024
|
James L. Cave INTERIM CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,885
+5.49%
|
-
|
|
May 31
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,768
+3.06%
|
-
|
|
May 31
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+5.38%
|
-
|
|
May 31
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,407
-10.56%
|
$37,477
$11.21 P/Share
|
|
May 31
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,117
+4.65%
|
-
|
|
May 31
2024
|
Laizer Kornwasser Advisor to the CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,352
+4.71%
|
-
|
|
May 31
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,313
+5.43%
|
-
|
|
May 31
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
5,504
+4.62%
|
-
|
|
May 31
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,023
+3.81%
|
-
|
|
May 31
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,804
+4.55%
|
-
|
|
May 23
2024
|
Karen L Daniel Director |
SELL
Open market or private sale
|
Direct |
9,834
-21.0%
|
$108,174
$11.9 P/Share
|
|
May 22
2024
|
Catherine Jacobson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,834
+32.53%
|
-
|
|
May 22
2024
|
Karen L Daniel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,834
+17.36%
|
-
|
|
May 22
2024
|
Thomas Mckinley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,834
+29.0%
|
-
|
|
May 22
2024
|
David B Snow Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,834
+12.87%
|
-
|
|
May 22
2024
|
David L Shedlarz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,834
+39.9%
|
-
|
|
May 17
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-3.82%
|
$12,000
$12.83 P/Share
|
|
May 02
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,691
-11.24%
|
$44,292
$12.69 P/Share
|
|
May 02
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,793
-8.2%
|
$69,516
$12.69 P/Share
|
|
May 02
2024
|
Laizer Kornwasser Advisor to the CEO |
SELL
Open market or private sale
|
Direct |
10,411
-10.79%
|
$124,932
$12.69 P/Share
|
|
May 01
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,244
+23.77%
|
-
|
|
May 01
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,319
+13.8%
|
-
|
|
May 01
2024
|
Laizer Kornwasser Advisor to the CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,198
+17.31%
|
-
|
|
Apr 17
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-3.68%
|
$13,000
$13.21 P/Share
|
|
Apr 02
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
461
-0.65%
|
$6,454
$14.31 P/Share
|
|
Apr 01
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,232
+1.7%
|
-
|